CSS LLC’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

CSS LLC’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,795	Closed	-$1.28K	–	1166
2024 Q4	$1.28K	Hold	12,795	–	–	﹤0.01%	950
2024 Q3	$905	Hold	12,795	–	–	﹤0.01%	811
2024 Q2	$1.25K	Hold	12,795	–	–	﹤0.01%	864
2024 Q1	$2.04K	Hold	12,795	–	–	﹤0.01%	792
2023 Q4	$1.03K	Buy	+12,795	New	+$1.73K	﹤0.01%	784
2023 Q3	–	Sell	-37,600	Closed	-$7.52K	–	983
2023 Q2	$7.52K	Buy	+37,600	New	+$6.61K	﹤0.01%	849

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

CSS LLC's NKGNW Position: Q1 2025 in Review

CSS LLC sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2025, closing a stake of 12,795 shares — an estimated $1.28K sold.

CSS LLC first reported a position in NKGNW in Q2 2023 and held it in 6 quarters. The position peaked at $7.52K in Q2 2023. 3 funds tracked by Wall St. Rank hold NKGNW as of Q1 2025.

CSS LLC reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2025 after selling out during the quarter.
CSS LLC sold 12,795 NKGen Biotech, Inc. Warrants shares in Q1 2025, an estimated $1.28K.
CSS LLC first reported a position in NKGen Biotech, Inc. Warrants in Q2 2023 and held it in 6 quarters.
CSS LLC's NKGen Biotech, Inc. Warrants position peaked at $7.52K in Q2 2023.
3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2025.

Based on CSS LLC's 13F filing for Q1 2025, filed 15 May 2025.